Эффективные средства профилактики повторногоишемического инсульта: оптимизацияантитромбоцитарной терапии

1. Дамулин И.В., Парфенов В.А., Скоромец А.А., Яхно Н.Н. Нарушения кровообращения в головном и спинном мозге. В кн.: Болезни нервной системы. Руководство для врачей. Под ред. Н.Н.Яхно. М.: Медицина, 2005; 1: 231–302.
2. Инсульт: диагностика, лечение и профилактика. Под ред. З.А.Суслиной, М.А.Пирадова. М.: МЕДпресс-информ, 2008.
3. Фейгин В., Виберс Д., Браун Р. Инсульт: Клиническое руководство. М.: Бином; СПб.: Диалект, 2005.
4. Amarenco P, Bogousslavsky J, Amarenco P et al. High- dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549–59.
5. Bak S, Sindrup SH, Alslev T et al. Cessation of smoking after first-ever stroke: a follow-up study. Stroke 2002; 33: 2263–9.
6. Bhatt D, Fox K, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706–17.
7. CAPRIE Streering Commitee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996; 348: 1329–39.
8. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration. BMJ 2002; 324: 71–86.
9. Diener HC, Cunha L, Forbes C et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1–13.
10. The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet 2006; 367: 1665–73.
11. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008; 25: 457–507.
12. Haas WK, Easton JD, Adams HP et al. A randomised trial comparing ticlopedine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989; 329: 501–7.
13. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.
14. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003; 34: 2475–81.
15. Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004; 35: 776–85.
16. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995; 108: 710–7.
17. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient schaemic attack. Lancet 2001; 358: 1033–41.
18. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34: 2741–8.
19. Reynolds K, Lewis B, Nolen JD et al. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 2003; 289: 579–88.
20. Ringleb PA, Bhatt DL, Hirsch AT et al. For the Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke 2004; 35: 528–32.
21. Rothwell PM, Howard SC, Spence JD, for the Carotide Endarterectomy Trialist`s Collaboration. Relationship between Blood Pressure and Stroke Risk in Patients With Symptomatic Carotid Occlusive Disease. Stroke 2003; 34: 2583–92.
22. Rothwell PM, Eliasziw M, Gutnikov SA et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915–24.
23. Sacco RL, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577–617.
24. Sacco RL, Diene HC, Yusuf S et al. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke. N Engl J Med 2008; 359: 1238–51.
25. Schrander J, Luders S, Kulschewski A et al. Morbidity and mortality after stroke, eprosaran compared with netrendipine for secondary prevention (MOSES study). Stroke 2005; 36: 1218–26.
26. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995; 274: 155–60.
27. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145–53.
28. The ACTIVE Investigators Effect of сlopidogrel аdded to aspirin in patients with atrial fibrillation. N Engl J Med 2009; 360: 2066–78.